Glaucoma Trial, Recruiting NCT06991270 Sponsor: Sight Sciences, Inc. Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT06991270
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 45 years of age or older
  • You have a cataract that affects your vision and need cataract surgery, OR you have already had cataract surgery at least 6 months ago
  • The pressure in your eye is within a specific range — either at least 21 mmHg without eye pressure-lowering drops, or at least 16 mmHg if you are using 1 to 4 eye pressure-lowering medications, and your medication routine has been stable for at least 2 months (confirm with trial site)
  • You have been diagnosed with mild to moderate primary open-angle glaucoma, with evidence of damage to the optic nerve or changes to your field of vision caused by glaucoma

Who may not be able to join:

  • You have had a laser treatment for glaucoma (laser trabeculoplasty) within the last 6 months
  • You have received a Durysta implant (a type of glaucoma medication placed in the eye) within the last 12 months
  • You have any kind of implanted glaucoma device already in your eye
  • You have previously had certain types of glaucoma surgery, including canaloplasty, goniotomy, trabeculotomy, or trabeculectomy
  • You have had certain procedures to reduce fluid production in the eye (ciliary ablation procedures) within the last 6 months (confirm with trial site)
  • You have had a laser procedure on your retina within the last 3 months
  • You have any type of glaucoma other than primary open-angle glaucoma
  • You are currently using steroid eye drops
  • You have another significant eye condition or serious health condition that the doctor believes could put you at risk during the study — for example, wet macular degeneration, corneal swelling, active eye infection, or inflammation within the last 30 days (dry macular degeneration and certain diabetic eye conditions are not excluded)
  • You have had a corneal transplant, or you have a corneal condition such as keratoconus, or your cornea is unusually thick or thin (confirm with trial site)
  • You have a tumour behind the eye, thyroid eye disease, Sturge-Weber Syndrome, or another condition that raises pressure in the veins around the eye
  • Your best corrected vision in the eye being studied is 20/50 or worse, for a reason other than cataracts
  • Your best corrected vision in your other eye is 20/80 or worse, for a reason other than cataracts

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +1 (817) 845-0859

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sight Sciences, Inc.
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
31 August 2026

Where this trial is recruiting

Panama

Primary endpoints

Primary Effectiveness Endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov